HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.

Future Market Insights (FMI) today announced new findings from its latest flagship report on the GLP-1 Receptor Agonist Market, highlighting powerful growth momentum as pharmaceutical manufacturers ...